- Meeting abstracts
- Open Access
Upregulation of angiopoietin-like 4 by viral G protein-coupled receptor promotes angiogenesis and vascular permeability in Kaposi’s sarcoma
Infectious Agents and Cancer volume 5, Article number: A84 (2010)
Kaposi’s sarcoma (KS) is an enigmatic vascular tumor thought to be a consequence of dysregulated expression of the human herpesvirus-8 (HHV-8 or KSHV)-encoded G protein-coupled receptor (vGPCR) . Both human and vGPCR experimental KS lesions are characterized by prominent angiogenesis and vascular permeability attributed to the paracrine release of angiogenic mediators, most notably vascular endothelial growth factor (VEGF). To date, the relative contribution of these paracrine mediators to the angiogenic and exudative phenotype of KS lesions remains unclear. Here we show that vGPCR upregulated angiopoietin-like 4 (ANGPTL4) (Figure 1A, 1B, 1C) plays a prominent role in promoting the angiogenesis and increasing vascular permeability in this tumor. Inhibition of ANGPTL4 effectively blocks vGPCR promotion of angiogenesis and vascular permeability in vitro and tumorigenesis in vivo (Figure 1D , 1E, 1F, 1G , 1H).
These observations suggest that ANGPTL4 is a previously unrecognized target for the treatment of patients with KS. As angiogenesis and increased vessel permeability are common themes in all solid tumors, these results may have a broad impact on our understanding and treatment of cancer.
Moore PS, Chang Y: Kaposi's sarcoma-associated herpesvirus-encoded oncogenes and oncogenesis. J Natl Cancer Inst Monogr. 1998, 23: 65-71.
Ganem D: Human herpesvirus 8 and its role in the genesis of Kaposi's sarcoma. Curr Clin Top Infect Dis. 1998, 18: 237-251.
Montaner S: et al, The Kaposi's sarcoma-associated herpesvirus G proteincoupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Cancer Res. 2006, 66 (1): 168-174. 10.1158/0008-5472.CAN-05-1026.
This work was supported by grant R01CA119911 (National Cancer Institute, NIH). We thank Histoserv, Inc., for its assistance in the processing of the murine tissues. BCJ is a recipient of a predoctoral fellowship from the CNPq-Brazil.
This article has been published as part of Infectious Agents and Cancer Volume 5 Supplement 1, 2010: Proceedings of the 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI).The full contents of the supplement are available online at http://www.biomedcentral.com/1750-9378/5?issue=S1.
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Ma, T., Jham, B.C., Hu, J. et al. Upregulation of angiopoietin-like 4 by viral G protein-coupled receptor promotes angiogenesis and vascular permeability in Kaposi’s sarcoma. Infect Agents Cancer 5 (Suppl 1), A84 (2010). https://doi.org/10.1186/1750-9378-5-S1-A84
- Vascular Endothelial Growth Factor
- Infectious Disease
- Cancer Research
- Solid Tumor